Interestingly, disease-associated TEX in chronic infection were further characterized by co-expression of inhibitory receptors TIGIT and 2B4 (as well as some KLRG1 and CD160) while in cancer, TEX more frequently exhibited higher expression of CTLA-4, Lag-3, and CD39. This evidence concerns the gene CD160 and cancer.